Asfotase alfa
Strensiq (asfotase alfa) is an enzyme pharmaceutical. Asfotase alfa was first approved as Strensiq on 2015-08-28. It is used to treat hypophosphatasia in the USA. It has been approved in Europe to treat hypophosphatasia.
| Trade Name | Strensiq |
|---|---|
| Common Name | Asfotase alfa |
| Indication | hypophosphatasia |
| Drug Class | Enzymes |
